The use of tumor markers (especially alpha-fetoprotein, AFP) alone is currently not recommended for HCC screening, but the combination of AFP and B-mode US is endorsed by Eastern countries [15,16]. The gene discussed is AFP; the disease is hepatocellular carcinoma.